DURATA THERAPEUTICS INC COM STK (DE)
DRTX
DRTX was delisted on the 17th of November, 2014.
59 hedge funds and large institutions have $172M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 5 closing their positions.
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
122% more call options, than puts
Call options by funds: $102K | Put options by funds: $46K
28% more funds holding
Funds holding: 46 → 59 (+13)
5% more capital invested
Capital invested by funds: $164M → $172M (+$8.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$6.94M |
| 2 |
SC
Sophrosyne Capital
New York
|
+$1.38M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$1.26M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$959K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$842K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.27M |
| 2 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$3.27M |
| 3 |
BC
Broadfin Capital
New York
|
-$2.41M |
| 4 |
Millennium Management
New York
|
-$2.16M |
| 5 |
AC
Aisling Capital
New York
|
-$1.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $46K | +$5.97K | +456 | +15% |
|
52
Citigroup
New York
| $19K | -$62.5K | -4,772 | -77% |
|
|
LTFS
53
Ladenburg Thalmann Financial Services
Miami,
Florida
| $13K | – | – | – |
|
|
U
54
UBS
Zurich,
Switzerland
| $12K | +$6.18K | +472 | +114% |
|
55
ClearBridge Investments
New York
| $9K | +$9.17K | +700 | New |
|
56
Barclays
London,
United Kingdom
| $5K | +$878 | +67 | +23% |
|
|
TDC
57
Thompson Davis & Co
Richmond,
Virginia
| $3K | +$3.27K | +250 | New |
|
58
AllianceBernstein
Nashville,
Tennessee
| $2K | – | – | – |
|
59
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $149 | -$23.1K | -1,760 | -14% |
|
|
BC
60
Broadfin Capital
New York
| – | -$2.41M | -188,706 | Closed |
|
61
Alyeska Investment Group
Chicago,
Illinois
| – | -$640K | -50,000 | Closed |
|
62
JP Morgan Chase
New York
| – | -$603K | -47,155 | Closed |
|
|
GI
63
Gradient Investments
Arden Hills,
Minnesota
| – | -$13K | -1,000 | Closed |
|
64
BNP Paribas Financial Markets
Paris,
France
| – | -$2.15K | -168 | Closed |
|
DRTX Hedge Fund Activity: Q1 2014 in Review
59 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q1 2014, worth a combined $172M — up 5.3% from $164M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new DRTX positions and 5 closed out — a net gain of 13 holders — while 13 added to existing stakes and 16 trimmed.
The largest buyer was Granahan Investment Management, opening a new position worth an estimated $6.94M. The largest seller was Wellington Management Group, cutting an estimated $4.27M.
- 59 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q1 2014, up from 46 in Q4 2013.
- Funds reported $172M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q1 2014, up 5.3% quarter-over-quarter.
- 18 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q1 2014 and 5 closed out, a net change of +13 holders.
- The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q1 2014 was Granahan Investment Management, an estimated $6.94M added.
- The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q1 2014 was Wellington Management Group, an estimated $4.27M sold.
Based on aggregated 13F filings for Q1 2014.